Choksi Laboratories Achieves 52-Week High Amid Broader Market Challenges

Choksi Laboratories, a microcap player in the healthcare services sector, has made headlines today as its stock price reached a new 52-week high of Rs. 203.35. This milestone was achieved on August 8, 2025, marking a significant performance boost for the company. Over the past eight days, Choksi Laboratories has demonstrated impressive momentum, gaining 16.87% during this period and outperforming its sector by 2.05%.
The stock opened at Rs. 203.35 and has maintained this price throughout the trading session, indicating strong market support. Notably, Choksi Laboratories is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a robust upward trend in its performance metrics.

In contrast, the broader market is experiencing challenges, with the Sensex declining by 429.37 points to 80,048.64, reflecting a negative sentiment after a weak opening. While the Sensex is trading below its 50-day moving average, Choksi Laboratories has shown resilience, with a remarkable one-year performance of 194.92%, significantly outpacing the Sensex's modest gain of 1.47%. The stock's 52-week low stands at Rs. 56.16, highlighting its substantial recovery over the past year.